Skip NavigationSkip to Content

NCI at Frederick Scientific Publications Advanced Search

Search

  1. NCI-F Publications

  2. Return to Quick Search
Search
  2. Year Published:

Your search returned 124 results.
User Information
Export Records
  1. 1.   The STAT3 inhibitor Stattic acts independently of STAT3 to decrease histone acetylation and modulate gene expression
  2. Poria,Dipak; Sheshadri, Namratha; Balamurugan, Kuppusamy; Sharan,Shikha; Sterneck, Esta
  3. Journal of Biological Chemistry. 2021, Jan-Jun; 296
  1. 2.   Whole-Cell Cancer Vaccines Induce Large Antibody Responses to Carbohydrates and Glycoproteins
  2. Xia, Li; Schrump, David S.; Gildersleeve, Jeffrey
  3. Cell Chemical Biology. 2016, Dec 22; 23(12): 1515-1525.
  1. 3.   Comparison of estrone and 17 beta-estradiol levels in commercial goat and cow milk
  2. Farlow, D. W.; Xu, X.; Veenstra, T. D.
  3. Journal of Dairy Science. 2012, Apr; 95(4): 1699-1708.
  1. 4.   Pressure-Assisted Protein Extraction: A Novel Method for Recovering Proteins from Archival Tissue for Proteomic Analysis
  2. Fowler, C. B.; Waybright, T. J.; Veenstra, T. D.; O'Leary, T. J.; Mason, J. T.
  3. Journal of Proteome Research. 2012, Apr; 11(4): 2602-2608.
  1. 5.   Common genetic variants in the PSCA gene influence gene expression and bladder cancer risk
  2. Fu, Y. P.; Kohaar, I.; Rothman, N.; Earl, J.; Figueroa, J. D.; Ye, Y.; Malats, N.; Tang, W.; Liu, L.; Garcia-Closas, M.; Muchmore, B.; Chatterjee, N.; Tarway, M.; Kogevinas, M.; Porter-Gill, P.; Baris, D.; Mumy, A.; Albanes, D.; Purdue, M. P.; Hutchinson, A.; Carrato, A.; Tardon, A.; Serra, C.; Garcia-Closas, R.; Lloreta, J.; Johnson, A.; Schwenn, M.; Karagas, M. R.; Schned, A.; Diver, W. R.; Gapstur, S. M.; Thun, M. J.; Virtamo, J.; Chanock, S. J.; Fraumeni, J. F.; Silverman, D. T.; Wu, X. F.; Real, F. X.; Prokunina-Olsson, L.
  3. Proceedings of the National Academy of Sciences of the United States of America. 2012, Mar; 109(13): 4974-4979.
  1. 6.   Invited Commentary: More Surprises From a Gene Desert
  2. Wacholder, S.; Yeager, M.; Liao, L. M.
  3. American Journal of Epidemiology. 2012, Mar; 175(6): 488-491.
  1. 7.   Impact of Circulating Vitamin D Binding Protein Levels on the Association between 25-Hydroxyvitamin D and Pancreatic Cancer Risk: A Nested Case-Control Study
  2. Weinstein, S. J.; Stolzenberg-Solomon, R. Z.; Kopp, W.; Rager, H.; Virtamo, J.; Albanes, D.
  3. Cancer Research. 2012, Mar; 72(5): 1190-1198.
  1. 8.   Restricted Replication of Xenotropic Murine Leukemia Virus-Related Virus in Pigtailed Macaques
  2. Del Prete, G. Q.; Kearney, M. F.; Spindler, J.; Wiegand, A.; Chertova, E.; Roser, J. D.; Estes, J. D.; Hao, X. P.; Trubey, C. M.; Lara, A.; Lee, K.; Chaipan, C.; Bess, J. W.; Nagashima, K.; Keele, B. F.; Macallister, R.; Smedley, J.; Pathak, V. K.; KewalRamani, V. N.; Coffin, J. M.; Lifson, J. D.
  3. Journal of Virology. 2012, Mar; 86(6): 3152-3166.
  1. 9.   Methoxychalcone inhibitors of androgen receptor translocation and function
  2. Kim, Y. S.; Kumar, V.; Lee, S.; Iwai, A.; Neckers, L.; Malhotra, S. V.; Trepel, J. B.
  3. Bioorganic & Medicinal Chemistry Letters. 2012, Mar; 22(5): 2105-2109.
  1. 10.   Immunological monitoring of the tumor immunoenvironment for clinical trials
  2. Malyguine, A. M.; Strobl, S. L.; Shurin, M. R.
  3. Cancer Immunology Immunotherapy. 2012, Feb; 61(2): 239-247.
  1. 11.   Antiangiogenic and antitumor activity of LP-261, a novel oral tubulin binding agent, alone and in combination with bevacizumab
  2. Gardner, E. R.; Kelly, M.; Springman, E.; Lee, K. J.; Li, H. Q.; Moore, W.; Figg, W. D.
  3. Investigational New Drugs. 2012, Feb; 30(1): 90-97.
  1. 12.   Immune suppression in the tumor microenvironment: a role for dendritic cell-mediated tolerization of T cells
  2. Hurwitz, A. A.; Watkins, S. K.
  3. Cancer Immunology Immunotherapy. 2012, Feb; 61(2): 289-293.
  1. 13.   Characterization, Mapping, and Distribution of the Two XMRV Parental Proviruses
  2. Cingoz, O.; Paprotka, T.; Delviks-Frankenberry, K. A.; Wildt, S.; Hu, W. S.; Pathak, V. K.; Coffin, J. M.
  3. Journal of Virology. 2012, Jan; 86(1): 328-338.
  1. 14.   EZH2 Mediates Epigenetic Silencing of Neuroblastoma Suppressor Genes CASZ1, CLU, RUNX3, and NGFR
  2. Wang, C. X.; Liu, Z. H.; Woo, C. W.; Li, Z. J.; Wang, L. F.; Wei, J. S.; Marquez, V. E.; Bates, S. E.; Jin, Q. H.; Khan, J.; Ge, K.; Thiele, C. J.
  3. Cancer Research. 2012, Jan; 72(1): 315-324.
  1. 15.   Biochemical, inhibition and inhibitor resistance studies of xenotropic murine leukemia virus-related virus reverse transcriptase
  2. Ndongwe, T. P.; Adedeji, A. O.; Michailidis, E.; Ong, Y. T.; Hachiya, A.; March, B.; Ryan, E. M.; Rai, D. K.; Kirby, K. A.; Whatley, A. S.; Burke, D. H.; Johnson, M.; Ding, S. L.; Zheng, Y. M.; Liu, S. L.; Kodama, E. I.; Delviks-Frankenberry, K. A.; Pathak, V. K.; Mitsuya, H.; Parniak, M. A.; Singh, K.; Sarafianos, S. G.
  3. Nucleic Acids Research. 2012, Jan; 40(1): 345-359.
  1. 16.   Hypoxia, stem cells and bone tumor
  2. Zeng, W.; Wan, R.; Zheng, Y. H.; Singh, S. R.; Wei, Y. Y.
  3. Cancer Letters. 2011, Dec; 313(2): 129-136.
  1. 17.   Global proteomics and metabolomics in cancer biomarker discovery
  2. Issaq, H. J.; Fox, S. D.; Chan, K. C.; Veenstra, T. D.
  3. Journal of Separation Science. 2011, Dec; 34(24): 3484-3492.
  1. 18.   The cancer stem cell niche-there goes the neighborhood?
  2. Cabarcas, S. M.; Mathews, L. A.; Farrar, W. L.
  3. International Journal of Cancer. 2011, Nov; 129(10): 2315-2327.
  1. 19.   Supplementation with alpha-Tocopherol or beta-Carotene Reduces Serum Concentrations of Vascular Endothelial Growth Factor-D, but Not -A or -C, in Male Smokers
  2. Mondu, A. M.; Rager, H. C.; Kopp, W.; Virtamo, J.; Albanes, D.
  3. Journal of Nutrition. 2011, Nov; 141(11): 2030-2034.
  1. 20.   Novel Substrate-Based Inhibitors of Human Glutamate Carboxypeptidase II with Enhanced Lipophilicity
  2. Plechanovova, A.; Byun, Y.; Alquicer, G.; Skultetyova, L.; Mlcochova, P.; Nemcova, A.; Kim, H. J.; Navratil, M.; Mease, R.; Lubkowski, J.; Pomper, M.; Konvalinka, J.; Rulisek, L.; Barinka, C.
  3. Journal of Medicinal Chemistry. 2011, Nov; 54(21): 7535-7546.
  1. 21.   The Bladder Tumor Suppressor Protein TERE1 (UBIAD1) Modulates Cell Cholesterol: Implications for Tumor Progression
  2. Fredericks, W. J.; McGarvey, T.; Wang, H. Y.; Lal, P.; Puthiyaveettil, R.; Tomaszewski, J.; Sepulveda, J.; Labelle, E.; Weiss, J. S.; Nickerson, M. L.; Kruth, H. S.; Brandt, W.; Wessjohann, L. A.; Malkowicz, S. B.
  3. DNA and Cell Biology. 2011, Nov; 30(11): 851-864.
  1. 22.   (-)-Epigallocatechin-3-gallate and DZNep reduce polycomb protein level via a proteasome-dependent mechanism in skin cancer cells
  2. Choudhury, S. R.; Balasubramanian, S.; Chew, Y. C.; Han, B. S.; Marquez, V. E.; Eckert, R. L.
  3. Carcinogenesis. 2011, Oct; 32(10): 1525-1532.
  1. 23.   Dissecting the diverse functions of the metastasis suppressor CD82/KAI1
  2. Tsai, Y. C.; Weissman, A. M.
  3. Febs Letters. 2011, Oct; 585(20): 3166-3173.
  1. 24.   Identification of Potential Protein Targets of Isothiocyanates by Proteomics
  2. Mi, L. X.; Hood, B. L.; Stewart, N. A.; Xiao, Z.; Govind, S.; Wang, X. T.; Conrads, T. P.; Veenstra, T. D.; Chung, F. L.
  3. Chemical Research in Toxicology. 2011, Oct; 24(10): 1735-1743.
  1. 25.   Human Monoclonal Antibody Fragments Binding to Insulin-like Growth Factors I and II with Picomolar Affinity
  2. Zhao, Q.; Feng, Y.; Zhu, Z. Y.; Dimitrov, D. S.
  3. Molecular Cancer Therapeutics. 2011, Sep; 10(9): 1677-1685.
NCI at Frederick

You are leaving a government website.

This external link provides additional information that is consistent with the intended purpose of this site. The government cannot attest to the accuracy of a non-federal site.

Linking to a non-federal site does not constitute an endorsement by this institution or any of its employees of the sponsors or the information and products presented on the site. You will be subject to the destination site's privacy policy when you follow the link.

ContinueCancel